ArticleBlood vessels, thrombosis & hemostasis2026

A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.

Edwin Spaans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.